Clinical Trials Directory

Trials / Unknown

UnknownNCT02702973

Characteristic Analysis of Retinopathy Associated With High Doses of Interferon α-2b Therapy

Characteristic Analysis of Retinopathy Associated With High Doses of Interferon α-2b Therapy in Patients With Melanomas of the Skin

Status
Unknown
Phase
Study type
Observational
Enrollment
1 (estimated)
Sponsor
The First Hospital of Jilin University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The high doses of interferon α-2b therapy in patients with melanomas of the skin may induced retinopathy, especially in the patients with hypertension or diabetes, so these patients should be followed up after treatment.

Detailed description

Patients with melanomas of the skin whose tumors have been resected completely were collected. The detailed ocular examinations including intraocular pressure, slit lamp microscope, indirect ophthalmoscope and color fundus photography were done before the induction therapy, 2 weeks after the induction therapy, after the whole course of induction therapy and each month in the maintenance treatment period. Fundus examinations were carried out by experienced ocular fundus doctors and the retinopathy characteristics were recorded.

Conditions

Interventions

TypeNameDescription
OTHERObserve the fundus characteristics after therapy.

Timeline

Start date
2015-12-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2016-03-09
Last updated
2016-03-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02702973. Inclusion in this directory is not an endorsement.